Peripheral primitive neuroectodermal tumors in adults: Documentation by molecular analysis

Journal of Clinical Oncology

Volumn 16, Issue 3, 1998, Pages 1150-1157

  Lawlor, Elizabeth R ^a   Mathers, Joan A ^a   Bainbridge, Terry ^a   Horsman, Doug E ^a   Kawai, Akira ^a   Healey, John H ^a   Huvos, Andrew G ^a   Bridge, Julia A ^a   Ladanyi, Marc ^a   Sorensen, Poul H B ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; FEMALE; GENE EXPRESSION; GENE FUSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR GENETICS; NEUROECTODERM TUMOR; PRIORITY JOURNAL; SOFT TISSUE TUMOR;

EID: 0031935403     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.3.1150     Document Type: Article

References (44)

1. Horowitz ME, Malawer MM, Delaney TF, et al: Ewing's sarcoma family of tumors, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology. Philadelphia, PA, Lippincott, 1993, pp 795-821
2. Pritchard DJ: Small round cell tumors. Orthop Clin North Am 20:367-375, 1989
3. Triche TJ: Unique features of childhood cancer, in Holland JF, Frei E, Bast RC, et al (eds): Cancer Medicine. Philadelphia, PA, Lea & Febiger, 1993, pp 2144-2152
4. Enzinger FM, Weiss SW: Soft Tissue Tumors. St Louis, MO, Mosby, 1988
5. Triche TJ: Pathology of pediatric malignancies, in Pizzo PA, Poplack DG: Principles and Practice of Pediatric Oncology. Philadelphia, PA, Lippincott, 1993, pp 115-152
6. Kovar H, Dworzak M, Strehl S, et al: Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene 5:1067-1070, 1990
7. Ambros IM, Ambros PF, Strehl S, et al: MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 67:1886-1893, 1991
8. MIC2 antigen and molecular detection of EWS rearrangements for the diasnosis of Ewing's sarcoma and peripheral neuroectodermal tumor. Hum Pathol 27:408-416, 1996
9. Turc-Carel C, Aurias A, Mugneret F, et al: Chromosomes in Ewing's sarcoma. I: An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 32:229-238, 1988
10. Delattre O, Zucman J, Ploustagel B, et al: Gene fusion with an ETS DNA binding domain caused by chromosome translocation in human cancers. Nature 359:162-165, 1992
11. May WA, Gishizky ML, Lessnick SL, et al: Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 90:5752-5756, 1993
12. Sorensen PHB, Lessnick SL, Lopez-Terrada D, et al: A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genet 6:146-151, 1994
13. Peter M, Couturier J, Pacquement H, et al: A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159-1164, 1997
14. Jeon I-S, Davis JN, Braun BS, et al: A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10:1229-1234, 1995
15. Urano F, Umezawa A, Hong W, et al: A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun 219:608-612, 1996
16. May WA, Lessnick SL, Braun BS, et al: The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13:7393-7398, 1993
17. Ohno T, Rao VN, Reddy SP: EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res 53:5859-5863, 1993
18. Bailly R-A, Bosselut R, Zucman J, et al: DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 14:3230-3241, 1994
19. Lessnick SL, Braun BS, Denny CT, et al: Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene 10:423-431, 1995
20. Sorensen PHB, Triche TJ: Gene fusions encoding chimaeric transcription factors in solid tumours. Semin Cancer Biol 7:3-14, 1996
21. Delattre O, Zucman J, Melot T, et al: The Ewing family of tumors - A subgroup of small round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294-299, 1994
22. Sorensen PHB, Liu XF, Thomas G, et al: Reverse transcriptase PCR amplification of EWS/Fli-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diag Mol Pathol 2:147-157, 1993
23. Barr FG, Chatten J, D'Cruz CM, et al: Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 273:553-557, 1995
24. Ladanyi M: The emerging molecular genetics of sarcoma translocations. Diag Mol Pathol 4:162-173, 1995
25. Sandberg AA, Bridge JA: The Cytogenetics of Bone and Soft Tissue Tumors. Austin, TX, Landes Co, 1994
26. Mitelman F: ISCN (1995): An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
27. Turc-Carel C, Philip I, Berger MP, et al: Chromosomal translocation in Ewing's sarcoma. N Engl J Med 309:497-498, 1983
28. Whang-Peng J, Triche TJ, Knutsen T, et al: Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 311:584-585, 1984
29. Zucman J, Melot T, Desmaze C, et al: Combinatorial generation of variable fusion proteins in the Ewing family of tumours. Embo J 12:4481-4487, 1993
30. Renard AJS, Veth RPH, Pruszczynksi M, et al: Ewing's sarcoma of bone: Oncologic and functional results. J Surg Oncol 60:250-256, 1995
31. Rud NP, Reiman HM, Pritchard DJ, et al: Extraosseous Ewing's sarcoma. A study of 42 cases. Cancer 64:1548-1553, 1989
32. Wilkins RM, Pritchard DJ, Burgert EJ, et al: Ewing's sarcoma of bone. Experience with 140 patients. Cancer 58:2551-2555, 1986
33. Kushner BH, Hajdu SI, Gulati SC, et al: Extracranial primitive neuroectodermal tumors: The Memorial Sloan-Kettering Cancer Center experience. Cancer 67:1825-1829, 1991
34. Sinkovics JG, Plager C, Ayala AG, et al: Ewing sarcoma: Its course and treatment in 50 adult patients. Oncology 37:114-119, 1980
35. Siegel RD, Ryan LM, Antman KH: Adults with Ewing's sarcoma. Am J Clin Oncol 11:614-617, 1988
36. Bullimore JA: Ewing's sarcoma in adults. Clin Oncol 2:39-45, 1990
37. Moody MA, Norman AR, Tait D: Paediatric tumours in the adult population: The experience of the Royal Marsden Hospital 1974-1990, Med Pediatr Oncol 26:153-159, 1996
38. MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker. Appl Immunohistochem 2:231-240, 1994
39. Pui CH: Childhood leukemias. N Engl J Med 333:1618-1630, 1995
40. Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al: Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 14:1245-1251, 1996
41. Aurias A, Rimbaut C, Buffe D, et al: Chromosomal translocations in Ewing's sarcoma. N Engl J Med 309:496-497, 1983
42. Adams V, Hany MA, Schmid M, et al: Detection of t(11;22)(q24; q12) translocation breakpoint in paraffin-embedded tissue of the Ewing's sarcoma family by nested reverse transcription-polymerase chain reaction. Diagn Mol Pathol 5:107-113, 1996
43. Ladanyi M: The emerging molecular genetics of sarcoma translocations. Diag Molec Pathol 4:162-173, 1995
44. Argatoff LH, O'Connell JX, Mathers JA, et al: Detection of the EWS/WT1 gene fusion by reverse transcriptase-polymerase chain reaction in the diagnosis of intra-abdominal small round cell rumor. Am J Surg Pathol 20:406-412, 1996